Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 6/20 | 0.50 |
| ▸ | MKNK1 | Q9BUB5 | 7/20 | 0.49 |
| ▸ | MKNK2 | Q9HBH9 | 7/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ITK | Q08881 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6497388 | 0.89 | KDM4E (0.53) | IRAK4KDM4EALDH1A1POLBMAPK1 | |
| SCHEMBL6467418 | 0.87 | IRAK4 (0.45) | IRAK4MKNK2KDM4EALDH1A1MAPK1 | |
| SCHEMBL6499042 | 0.84 | KDM4E (0.49) | IRAK4MKNK1MKNK2KDM4EALDH1A1 | |
| SCHEMBL6468743 | 0.83 | SMPD1 (0.44) | IRAK4 | |
| SCHEMBL6507198 | 0.83 | MAP4K4 (0.47) | IRAK4MKNK1MKNK2KDM4EALDH1A1 | |
| SCHEMBL6498693 | 0.83 | KDM4E (0.46) | IRAK4KDM4EALDH1A1POLBMAPK1 | |
| SCHEMBL6504415 | 0.82 | KDM4E (0.50) | IRAK4KDM4EALDH1A1MAPK1NPC1 | |
| SCHEMBL6498765 | 0.81 | MAPT (0.46) | IRAK4KDM4EALDH1A1POLBMAPK1 | |
| SCHEMBL6470269 | 0.81 | MAPT (0.44) | KDM4EALDH1A1POLBMAPK1NPC1 | |
| SCHEMBL6501596 | 0.81 | IKBKB (0.47) | IRAK4KDM4EALDH1A1POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050197338-A1 | Substituted pyrazole urea compounds for the treatment of inflammation | PHARMACIA AND UPJOHN COMPANY LLC | 2005-09-08 | — | — | US | disclosed |
| WO-2005037797-A1 | SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | PHARMACIA CORPORATION (US) | 2005-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197338-A1 | Substituted pyrazole urea compounds for the treatment of inflammation | IL4, ARG2, CASP4 | IRAK4 27/4885MKNK1 3890/4885MKNK2 2808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.